SecSonar.com

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Verrica Pharmaceuticals Inc. (VRCA) is a Biotechnology company based in US with a market capitalization of $64.1M. Revenue grew 370.2% year-over-year and free cash flow was negative at -$17.6M. This page tracks VRCA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 71 employees · IPO Jun 15, 2018

Valuation

Valuation & price

$6.27 · as of May 17, 2026 · -31.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.59

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.10$6.19$3.28Jul 25Dec 25Jul 26Jul 7, 25$8.30Jul 9, 25$8.19Jul 11, 25$8.07Jul 15, 25$7.98Jul 17, 25$8.55Jul 21, 25$7.69Jul 23, 25$7.05Jul 25, 25$6.61Jul 29, 25$6.24Jul 31, 25$5.63Aug 4, 25$5.57Aug 6, 25$6.12Aug 11, 25$6.70Aug 13, 25$6.59Aug 15, 25$5.96Aug 19, 25$6.05Aug 21, 25$5.74Aug 25, 25$5.99Aug 27, 25$5.66Aug 29, 25$5.60Sep 3, 25$5.23Sep 5, 25$5.11Sep 9, 25$5.00Sep 11, 25$4.94Sep 16, 25$4.41Sep 18, 25$4.04Sep 22, 25$4.46Sep 24, 25$4.17Sep 26, 25$4.18Sep 30, 25$4.31Oct 2, 25$4.54Oct 6, 25$4.69Oct 8, 25$4.42Oct 10, 25$4.14Oct 14, 25$4.11Oct 16, 25$4.23Oct 21, 25$4.04Oct 23, 25$3.95Oct 27, 25$3.76Oct 29, 25$3.61Oct 31, 25$3.61Nov 4, 25$3.28Nov 6, 25$3.58Nov 10, 25$3.87Nov 12, 25$3.82Nov 14, 25$3.93Nov 18, 25$3.83Nov 20, 25$4.02Nov 25, 25$5.12Nov 28, 25$9.10Dec 2, 25$6.73Dec 4, 25$8.42Dec 8, 25$8.11Dec 10, 25$8.24Dec 12, 25$7.92Dec 16, 25$8.60Dec 18, 25$8.11Dec 22, 25$7.91Dec 24, 25$8.33Dec 29, 25$8.20Jan 2, 26$8.30Jan 6, 26$8.05Jan 8, 26$8.02Jan 12, 26$8.02Jan 14, 26$7.95Jan 16, 26$7.26Jan 21, 26$7.76Jan 23, 26$7.42Jan 27, 26$7.31Jan 29, 26$7.21Feb 2, 26$7.45Feb 4, 26$7.14Feb 9, 26$6.91Feb 11, 26$5.69Feb 13, 26$5.69Feb 18, 26$6.07Feb 20, 26$5.79Feb 24, 26$5.59Feb 26, 26$5.47Mar 2, 26$5.37Mar 4, 26$5.33Mar 6, 26$5.31Mar 10, 26$5.98Mar 12, 26$6.15Mar 17, 26$6.31Mar 19, 26$5.80Mar 23, 26$4.85Mar 25, 26$4.62Mar 27, 26$4.38Mar 31, 26$5.29Apr 2, 26$5.47Apr 7, 26$5.82Apr 9, 26$5.83Apr 13, 26$5.62Apr 15, 26$5.91Apr 17, 26$6.32Apr 22, 26$6.51Apr 24, 26$6.98Apr 28, 26$6.53Apr 30, 26$6.37May 4, 26$6.36May 6, 26$8.43May 8, 26$7.99May 12, 26$7.15May 14, 26$6.95May 18, 26$5.87May 20, 26$6.02May 22, 26$6.06May 28, 26$6.04Jun 1, 26$5.90Jun 3, 26$5.87Jun 5, 26$6.04Jun 9, 26$6.12Jun 11, 26$6.03Jun 15, 26$5.81Jun 17, 26$5.83Jun 22, 26$5.64Jun 24, 26$5.85Jun 26, 26$6.84Jul 2, 26$6.14
$3.2852-week range$9.10
Loading valuation history…

Fundamentals

Key fundamentals

$64.1M

Market cap

370.2%

Revenue growth (YoY)

90.3%

Gross margin

-$17.6M

Free cash flow (USD)

-$28.5M

Net debt

Net cash position

105.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$12.0MFY 2022$9.0MFY 2023$5.1MFY 2024$7.6MFY 2025$35.6M
$0$35.6M

Free cash flow by year

2016 → 2025

FY 2016$-1.6MFY 2017$-4.6MFY 2018$-18.6MFY 2019$-28.1MFY 2020$-31.7MFY 2021$-28.5MFY 2022$-19.0MFY 2023$-38.9MFY 2024$-61.0MFY 2025$-17.6M
-$1.6M-$17.6M

Gross margin by year

2021 → 2025

FY 202196.1%FY 202292.0%FY 202385.4%FY 202463.8%FY 202590.3%
96.1%90.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Incentive Plan AmendedJun 9, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing

Questions

Frequently asked questions

What is Verrica Pharmaceuticals Inc.'s market cap?

Verrica Pharmaceuticals Inc. (VRCA) has a market capitalization of $64.1M.

What is VRCA's P/E ratio?

A meaningful P/E ratio is not available for VRCA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VRCA's price-to-book (P/B) ratio?

VRCA trades at 2.59 times book value per share.

Are insiders buying VRCA stock?

SEC Form 4 filings show no open-market insider buys at Verrica Pharmaceuticals Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

RANI

Rani Therapeutics Holdings, Inc.

$63.5M

IMMP

Immutep Limited

$65M

IMA

ImageneBio Inc

$65.9M

MNOV

MediciNova, Inc.

$66M

ENTX

Entera Bio Ltd.

$62.3M

CBUS

Cibus, Inc.

$66.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.